Member Info for HenryHistorian

I agree but until the chunky profits are announced a chunky CEO / board member buy would signal confidence in their own company. In the absence of even such a simple gesture one wonders what confidence Bango management has in its company - wouldn't you agree?

I think a small US hedge fund bought a position...maybe they are the sellers.

Selling at these ridiculously low share price makes no sense to me...and whilst it is not nive to see I am relatively relaxed about it.

What I am not so relaxed about is that I don't see buys from Larbey. A good chunky investment from our CEO would be a strong signal to the market.

Judging by the past I do wonder (in my humble personal opinion) whether the board really has the interests of shareholders at heart.

I remember how tone-deaf everyone at Nanoco was to the outcry and dismay of Nanoco shareholders after the settlement capitulation.

Dear all,

I used to have a very sizeable holding in Nanoco and remember some contributors here (Feeks etc) - as I had trusted Brian Tenner the former CEO of Nanoco and his repeated assertions about the red lines he would uphold with regard to any settlement agreement. As all longstanding Nanoco shareholders know Tenner agreed to a pitytful and shameful settlement with Samsung despite Nanoco having the trump card. To this day I believe that there are many question marks around the conduct of Tenner and how this settlement panned out.

I was so fortunate to have liquidated a sizeable portion of Nanoco relatively soon after the settlement capitulation and than another good chunk when Nanoco bought back some of the shares. Thankfully I shifted some of these funds into a share that has repaid my faith and where I believe people with integrity are in charge.

Still, all Nanoco shareholders who are still holding shares in Nanoco have my full sympathy. I knew I had to get out entirely when the details of the settlement capitulation were published. On that day I lost all trust in Nanoco's leadership and once I loose trust in the leadership of a company I sell out.

This is what I can advise to everyone here: CEOs can't control everything and things might be beyond their control but once you have the feeling that questionable behaviour has been shown it is often best (in my humble personal opinion) to exit a share - we all have worked to hard for the funds we invest only to be let down by CEOs who couldn't care less about (retail) shareholders.

CrustyPete - I hear you and I am with you but I have been investing for long enough where I try to project to myself rather meagre outcome and ask myself "would I still make a good return if only these modest target prices are met?". So hence my deliberate very very modest targets in my below post.

Scancell could easily hit 30+p once news of a partnership deal lands via an RNS and above 50+p if we are taken out.

Both are real prospects and at our modest market cap we could be swallowed up without any problems by big pharma.

Well than we have almost the same price for our second bite of the cherry...you at 22p and me at 21.9p... looking forward to shaking hands on our Scancell investment with you.

I have to hold up my hand and I took off a small tranche at 26.1p....the profits of this tranche sell I reinvested at 21.9p.

I mean the distance from what the valuation of Scancell can be and 21.9p makes me firmly believe that I won't regret my reinvestment.

PS: And the only reason I took some profits off the table this morning was that I still have a mortgage to pay.

I think we should focus on the fact that there is a buyer / are buyers out there who has/have been taking shares. Today saw a bit of froth taken off but buying continued towards the close again.

I think we should also focus on the RNS regarding scientific updates than speculating left, right and centre on business decisions to which we are not privy.

I personally believe that if a major pharma likes our research/science they can easily partner with us or boy us outright - they don't need Scancell to be listed in Nasdaq for such a purpose.

Where are the director buys? This is what I find unsettling. Surely at this price a purchase over GBP 40000 would be a strong statement of belief and confidence…

What I find telling and disconcerting is that no senior management members are buying shares at the present level.

In the past they would so so.

At least senior management has enough skin in the game for them not to want Bango to flounder but at the moment they are not making great efforts either with sending signals to their investor base and to the wider market and as as old on and off Investor I find that disappointing.

@CrustyPete: I understand your frustrationb but here is my take:

1. Short term investor interest and buying can drive the share price up - but again the effect will only be short term...

2. SUSTAINABLE higher share price can only be sustained by Scancell eliciting concrete commercial interest from a medium/big pharma company through compelling trial results...

ATB!

@Paradisewanted: I really don't believe that West Elk know something that we don't know.... Bango is a company with integrity so I don't think they will disclose information that is market sensitiv/moving to outsiders...

I just think that the market completely overreacted in January 2024 and now needs some concrete reassurance - once we have this I look forward to seeing 130p and 150p later this year...

Me too - I think / suppose that Liontrust is still selling which is weighing down this share on a purely technical basis.

I guess and hope that the next trading update will help this share move upwards - I hope at least to 130p level...

@I WantThatOne: I hear you regarding the selling but if (as we all suspect) Liontrust needs to see due to their investors pulling money from their funds than there is little that Liontrust can do. I suspect that their portfolio managers must be frustrated as well - no fund manager wants to see good positions at low prices and even realise losses in the process (?).

Anyway in January we will know for certain how Bango is doing - all I can say is that in the past Bango was fair and honest in their communications with investors - so I remain tranquil.

@IWantThatOne: Yes, I also liked these paragraphs when I looked West Elk Capital up this morning.

This seems to be the patient investor that we would like to see on Bango's shareholder registry.

I notice coninuing selling and I suspect it is still the same seller, ie Liontrust. Once they have sold whatever they wanted to sell (their entire stake?) than the technical pressure on the share price will go away.

Let us hope that the next update is a positive on so that the pendulum swings upwards.

Good to see that a specialist US investor, Elk Capital, has taken a significant stake in Bango.

Not a big US investment firm but they seem to have good experience in telco and media so I take this as a good endorsement.

@Dracula1: The scientific results were great - but only once through a RNS we can be sure that the funding basis is firm will there be a sustained uplift.

With every good scientific RNS our negotiation position is improving - in the hands of the right management team.

@casualinvestor: Yes, it is very odd. Two things: Liontrust has sold a significant amount of its holdings - something that is due to them facing themselves outflows from investors. So this is putting downward technical pressure on Bango. Apart from that some retail investors selling ..but as far as I can see only small holdings so definitely not a stampede.

Whilst I would wish the share price to be higher I am really relaxed. The management of Bango has significant skin in the game and if management says that they will meet their targets I believe them.

In the past I found Bango to be honest in their communication.

It seems to me that after the update in January 2023 Bango receovered from ridiculous lows but then in the summer Liontrust started to seel (see reason above) and retail investors didn't really rush to fill the gap. Given that there were few recent announcements totally understandable...but if the next RNS in January is a good one Bango should rally significantly - as it has done so in the past.

All this is my personal opinion.

As far as I can see a rotation is going on. A big seller is selling (probably the one that has been selling for some time) and someone else is stepping in.

I am fine with this. The seller will be gone in a time not too distant in the future and than it will be only the PIs and insti investors who believe in Scancell... in other words the technical downside pressure on the share price will go away but (hopefully) not the scientific case for an investment.